Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
—
Company details
Market cap
~$9B
Revenue (2025)
$2.9B
FFO/sh (adj)
$9.01
Div yield
~5.9%
Net income
loss
Rev. growth
-4%
Total debt
~$13B
Portfolio
~39M sq ft
In plain English
Alexandria is the pioneer and largest landlord of life-science lab space — the 'Megacampus' clusters in Boston, the San Francisco Bay Area and San Diego where biotech and pharma do their research. Big drugmakers like Bristol Myers Squibb, Eli Lilly and Moderna rent its labs on long leases, the rent flows back to shareholders as dividends, and a venture arm seeds the next generation of tenants. In late 2025 it cut its dividend 45% to weather a deep life-science oversupply slump.
In simple terms
What Alexandria Real Estate Equities really sells
Alexandria is the pioneer and largest landlord of life-science lab space — the 'Megacampus' clusters in Boston, the San Francisco Bay Area and San Diego where biotech and pharma do their research. Big drugmakers like Bristol Myers Squibb, Eli Lilly and Moderna rent its labs on long leases, the rent flows back to shareholders as dividends, and a venture arm seeds the next generation of tenants. In late 2025 it cut its dividend 45% to weather a deep life-science oversupply slump.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.